In vivo, RO76 provided strong MOR-mediated analgesic effects with fewer adverse outcomes compared with morphine, including reduced respiratory depression and physical dependence [4]. This evidence concerns the gene OPRM1 and Respiratory insufficiency due to muscle weakness.